MedTrace Logo

Effects of Dry Needling When Applied to the Infraspinatus Muscle in People With Chronic Shoulder Pain

NCT04316793 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2020-03-20

No results posted yet for this study

Summary

Up to 77% of patients with chronic shoulder pain have a trigger point (TrP) in the infraspinatus muscle. These TrPs can lead to pain, limitation of activities and reduced quality of life. Dry needling (DN) is gaining popularity as a treatment for TrPs in physiotherapy. However, its clinical effects remain poorly understood mechanistically and its neurophysiological effects little studied.

The primary objective of this study is to determine the feasibility of a larger scale study.

The secondary objective of this study is to to explore the immediate neurophysiological, biomechanical and clinical effects of DN and sham needling when applied to TrP of the infraspinatus muscle in people with chronic non-traumatic shoulder pain.

Conditions

  • Trigger Point Pain, Myofascial
  • Chronic Shoulder Pain

Interventions

OTHER

Dry needling

Intramuscular insertion of an OPTIMED 40mm x 0.3mm acupuncture needle in a trigger point of the infraspinatus muscle

OTHER

Sham needling (SN)

Intradermal insertion of an OPTIMED 40mm x 0.3mm acupuncture needle over the infraspinatus region

Sponsors & Collaborators

  • Ordre Professionnel de la Physiothérapie du Québec (OPPQ)

    collaborator UNKNOWN

  • Centre de recherche du Centre hospitalier universitaire de Sherbrooke

    collaborator OTHER

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Nathaly Gaudreault, PhD · Université de Sherbrooke

  • Mélanie Morin, PhD · Université de Sherbrooke

  • Guillaume Léonard, PhD · Université de Sherbrooke

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-03
Primary Completion
2019-12-20
Completion
2019-12-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04316793 on ClinicalTrials.gov